Skip to content
★ Sign in to follow
ES

Eugene Seymour

Nanoviricides, Inc.
Total declarations
4
Company
1
▲ Purchases (1 ops.)
€13k
▼ Sales (0 ops.)
—

Latest filing published 24 Sept 2015 for NANOVIRICIDES, INC., €33k.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 11 Mar 2013 · 4991 days ago · €13k
    +41.7%
    Entry US$53.90 · Close at T+365 US$76.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Eugene Seymour: trading record in brief

Eugene Seymour appears in our data through filings on Nanoviricides, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 12 November 2010 to 22 September 2015.

Purchases make up the whole of the open-market record (1 purchase, €13k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 1 option exercise.

The newest entry dates from 24 September 2015: an option exercise of €33k, in Nanoviricides, Inc. The last purchase on record was published on 11 March 2013, which is 4,991 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Eugene Seymour

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◇
    Chief Executive OfficerExecutivesNanoviricides, Inc.
    36,534 USD0SEC
    104,384 shares@ US$0.35Common Stock, par value $0.001 per shareSEC:0001140361-15-035878:0
  • ◆
    Chief Executive OfficerExecutivesNanoviricides, Inc.
    50,014 USD0SEC
    38,472 shares@ US$1.30Common Stock, par value $0.001 per shareSEC:0001140361-15-035878:1
  • ▲
    Chief Executive OfficerExecutivesNanoviricides, Inc.
    17,250 USD0SEC
    25,000 shares@ US$0.69Common StockSEC:0001140361-13-011894:0
    Canonical exit: 4 Jun 2013 (T+90)
  • ●
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    2,500,000 shares0Common StockSEC:0001140361-10-046316:0

4 of 4 declarations